Submitted by labiotecheu9957 in science
Prime editing, a mightier version of CRISPR/Cas9, has been greenlit by the FDA to begin the first-ever clinical trial for this technology.
Submitted by labiotecheu9957 in science
Prime editing, a mightier version of CRISPR/Cas9, has been greenlit by the FDA to begin the first-ever clinical trial for this technology.